TickerKhojComparison · NSE · data 2026-11-02
Hikal Limited vs Solara Active Pharma Sciences Ltd.
In plain words
Size: Solara Active Pharma Sciences Ltd. is about 1.2 times the market value of Hikal Limited.
Return on equity: Solara Active Pharma Sciences Ltd. -0.6% vs Hikal Limited -4%.
Differences in the numbers, not a recommendation of either stock.
Side by side
| HIKAL | SOLARA | |
|---|---|---|
| Price | ₹216.48 | ₹629.7 |
| Market cap | ₹2,601 cr | ₹3,043 cr |
| P/E | — | 83.8 |
| P/B | — | 2.1 |
| ROE | -4.0% | -0.6% |
| ROCE | 3.1% | 5.9% |
| Debt / equity | 0.57 | 0.55 |
| Operating margin | 3.8% | 8.4% |
| Dividend yield | 0.28% | 0.00% |
| Sales growth, 3 years (yearly) | -5.4% | -1.6% |
| Profit growth, 3 years (yearly) | — | — |
| 1-year return | -9.9% | 4.4% |
| Revenue, last 12 months | ₹1,735 cr | ₹1,535 cr |
| Net profit, last 12 months | ₹-34 cr | ₹37 cr |
| Latest quarter | Jun 2026 | Sept 2026 |
| Quarter net profit | ₹-7 cr | ₹28 cr |
| Quarter profit vs a year earlier | — | — |
| Promoter holding | 68.85% | 41.93% |
| Health check | Weak (1.1/10) | Weak (2.5/10) |
Common questions
Which earns a higher return on equity?
Solara Active Pharma Sciences Ltd. (-0.6% against -4.0%).
Which carries more debt?
Hikal Limited has the higher debt-to-equity ratio (0.57 against 0.55).